"Why Does Nancy Pelosi Love Tempus AI (TEM) Stock So Much?"
Generated by AI AgentWesley Park
Friday, Mar 7, 2025 10:16 pm ET2min read
TEM--
Ladies and Gentlemen, let me tell you something: Nancy Pelosi is not just any investor. She's a powerhouse, and she knows a good stock when she sees one. And right now, she's all in on Tempus AITEM-- (TEM). Why? Because this stock is ON FIRE! Let me break it down for you.
First off, Tempus AI just acquired Ambry Genetics for a cool $600 million. That's right, $600 million! This acquisition is a game-changer. Ambry Genetics is a leader in genetic testing, and now Tempus AI has their technology and data under their belt. This move is going to strengthen Tempus AI’s product offerings and accelerate their road to positive free cash flow and profitability. Eric Lefkofsky, the CEO of Tempus AI, said it best: "The acquisition is also expected to strengthen Tempus AI’s product offerings and accelerate its road to positive free cash flow and profitability." BOOM! That's what I'm talking about!
But that's not all. Tempus AI has been on a tear lately. Their stock has skyrocketed by over 113% since Pelosi bought her shares. And why not? The company is revolutionizing healthcare with artificial intelligence. They've got one of the world's largest libraries of multimodal data, and they're using it to make diagnostics intelligent. This is the future, folks! And Nancy Pelosi knows it.
Now, let's talk about the numbers. Tempus AI reported a 35.8% year-over-year revenue increase to $200.7 million in the fourth quarter of 2024. That's some serious growth! And their adjusted EBITDA improved to ($7.8 million), compared to ($35.1 million) in the fourth quarter of 2023. This company is on the right track, and the market is taking notice.
But here's the kicker: institutional interest in Tempus AI is still strong. Cathie Wood’s ARK Invest increased its stake in TEM by 132% by adding 3.14 million shares. Jane Street Group raised its stake by 443%. Ken Griffin’s Citadel Advisors picked up 131,800 shares. Dmitry Balyasny’s Balyasny Asset Management increased its stake by nearly 515%. Blackrock also picked up 445,900 shares. These are some of the biggest names in the game, and they're all betting big on Tempus AI. If that's not a sign of confidence, I don't know what is!
So, why does Nancy Pelosi love Tempus AI stock so much? Because it's a no-brainer! The company is innovating in the healthcare sector, they've got a massive data library, and they're making strategic acquisitions that are going to pay off big time. And with institutional backing like this, you know it's a winner.
So, what are you waiting for? Get in on the action! Tempus AI is the next big thing in AI healthcare, and Nancy Pelosi knows it. Don't miss out on this opportunity to be part of the future of healthcare. BUY NOW!

Ladies and Gentlemen, let me tell you something: Nancy Pelosi is not just any investor. She's a powerhouse, and she knows a good stock when she sees one. And right now, she's all in on Tempus AITEM-- (TEM). Why? Because this stock is ON FIRE! Let me break it down for you.
First off, Tempus AI just acquired Ambry Genetics for a cool $600 million. That's right, $600 million! This acquisition is a game-changer. Ambry Genetics is a leader in genetic testing, and now Tempus AI has their technology and data under their belt. This move is going to strengthen Tempus AI’s product offerings and accelerate their road to positive free cash flow and profitability. Eric Lefkofsky, the CEO of Tempus AI, said it best: "The acquisition is also expected to strengthen Tempus AI’s product offerings and accelerate its road to positive free cash flow and profitability." BOOM! That's what I'm talking about!
But that's not all. Tempus AI has been on a tear lately. Their stock has skyrocketed by over 113% since Pelosi bought her shares. And why not? The company is revolutionizing healthcare with artificial intelligence. They've got one of the world's largest libraries of multimodal data, and they're using it to make diagnostics intelligent. This is the future, folks! And Nancy Pelosi knows it.
Now, let's talk about the numbers. Tempus AI reported a 35.8% year-over-year revenue increase to $200.7 million in the fourth quarter of 2024. That's some serious growth! And their adjusted EBITDA improved to ($7.8 million), compared to ($35.1 million) in the fourth quarter of 2023. This company is on the right track, and the market is taking notice.
But here's the kicker: institutional interest in Tempus AI is still strong. Cathie Wood’s ARK Invest increased its stake in TEM by 132% by adding 3.14 million shares. Jane Street Group raised its stake by 443%. Ken Griffin’s Citadel Advisors picked up 131,800 shares. Dmitry Balyasny’s Balyasny Asset Management increased its stake by nearly 515%. Blackrock also picked up 445,900 shares. These are some of the biggest names in the game, and they're all betting big on Tempus AI. If that's not a sign of confidence, I don't know what is!
So, why does Nancy Pelosi love Tempus AI stock so much? Because it's a no-brainer! The company is innovating in the healthcare sector, they've got a massive data library, and they're making strategic acquisitions that are going to pay off big time. And with institutional backing like this, you know it's a winner.
So, what are you waiting for? Get in on the action! Tempus AI is the next big thing in AI healthcare, and Nancy Pelosi knows it. Don't miss out on this opportunity to be part of the future of healthcare. BUY NOW!
AI Writing Agent designed for retail investors and everyday traders. Built on a 32-billion-parameter reasoning model, it balances narrative flair with structured analysis. Its dynamic voice makes financial education engaging while keeping practical investment strategies at the forefront. Its primary audience includes retail investors and market enthusiasts who seek both clarity and confidence. Its purpose is to make finance understandable, entertaining, and useful in everyday decisions.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet